Education
About Us
Working with TipRanks
Follow Us
Vext Science (VEXTF)
:VEXTF
Earnings Data
Report Date
Aug 26, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
>-0.01Last Year’s EPS
>-0.01Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 21, 2025
|% Change Since: 25.00%
|Next Earnings Date:Aug 26, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive momentum for Vext, driven by significant revenue growth, robust cash flow generation, and successful expansion in Ohio. Despite challenges in pricing pressure and market conditions in Ohio and Arizona respectively, Vext’s operational efficiency and strategic investments position the company well for continued growth. The highlights significantly outweigh the lowlights.Company Guidance
During the first quarter of 2025, Vext Science demonstrated strong financial performance, with revenue increasing by 38% year-over-year to $11.6 million, driven largely by the growth in Ohio's adult-use sales. The company reported an operating cash flow of $3.1 million, which significantly improved their cash flow margin to over 26%. Adjusted EBITDA reached $3.4 million, marking the strongest quarter in over two years, with a margin of 29%, one of the highest among U.S. public multi-state cannabis operators. Vext's retail sales in Ohio grew by 7% sequentially, while wholesale in the state surged by 92% compared to the previous quarter. The company aims to continue expanding its Ohio retail footprint, expecting to have seven stores operational by the end of the year, while maintaining a disciplined focus on generating free cash flow and optimizing operations in Arizona.Strong Revenue Growth
Vext's revenue increased to $11.6 million in Q1 2025, a 38% year-over-year increase, driven by strong growth in adult use sales in Ohio.
Robust Cash Flow Generation
Operating cash flow reached $3.1 million in Q1 2025, with a cash flow margin exceeding 26%, placing Vext among the top cash flow producers among U.S. Public multistate cannabis operators.
Expansion in Ohio
Successful acquisition of two dispensaries in Ohio, with retail locations in Athens and Jeffersonville growing 18% sequentially in Q1. Construction underway for a fifth store in Portsmouth, expected to open in Q2.
Operational Efficiency and Cost Control
Operating expenses remained flat compared to last year, with a decline from 54% of revenue in Q1 2024 to 38% in Q1 2025, reflecting cost discipline.
Strong Market Position in Arizona
Despite a 13% decline in the Arizona market, Vext's sales only declined 8.5%, leading to market share gains.
VEXTF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VEXTF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 21, 2025 | $0.08 | $0.08 | 0.00% |
Mar 31, 2025 | $0.13 | $0.12 | -7.69% |
Nov 21, 2024 | $0.14 | $0.14 | 0.00% |
Aug 20, 2024 | $0.18 | $0.17 | -5.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vext Science (VEXTF) report earnings?
Vext Science (VEXTF) is schdueled to report earning on Aug 26, 2025, TBA Not Confirmed.
What is Vext Science (VEXTF) earnings time?
Vext Science (VEXTF) earnings time is at Aug 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VEXTF EPS forecast?
VEXTF EPS forecast for the fiscal quarter 2025 (Q2) is >-0.01.